AZURRX BIOPHARMA (Germany) Today

Equity ratings for AZURRX BIOPHARMA DL are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of April 2021 and ending today, the 24th of July 2021. Click here to learn more.
AZURRX BIOPHARMA DL cannot be verified against its exchange. It appears AZURRX BIOPHARMA is not available for investing at the moment. Please verify the symbol is currently traded on Frankfurt Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

AZURRX BIOPHARMA Stock Profile

AzurRx BioPharma, Inc. researches and develops non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company was incorporated in 2014 and is headquartered in Brooklyn, New York. AZURRX BIOPHARMA operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12 people.. The public information regarding AZURRX BIOPHARMA DL's current market price is not available at this time.
AZURRX BIOPHARMA is not yet fully synchronised with the market data
AZURRX BIOPHARMA has some characteristics of a very speculative penny stock
AZURRX BIOPHARMA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has accumulated 2.18 M in total debt with debt to equity ratio (D/E) of 80.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AZURRX BIOPHARMA has a current ratio of 0.48, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Net Loss for the year was (14.56 M).
AZURRX BIOPHARMA DL has accumulated about 413.86 K in cash with (11.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Legal NameAZURRX BIOPHARMA DL
President CEO, DirectorJohan Spoor  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of AZURRX BIOPHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
AZURRX BIOPHARMA DL (366) is traded on Frankfurt Stock Exchange in Germany and employs 12 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 24.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AZURRX BIOPHARMA's market, we take the total number of its shares issued and multiply it by AZURRX BIOPHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. AZURRX BIOPHARMA classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 0 outstanding shares. AZURRX BIOPHARMA DL has accumulated about 413.86 K in cash with (11.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check AZURRX BIOPHARMA Probability Of Bankruptcy

AZURRX Stock Against Markets

Picking the right benchmark for AZURRX BIOPHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AZURRX BIOPHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AZURRX BIOPHARMA is critical whether you are bullish or bearish towards AZURRX BIOPHARMA DL at a given time.
AZURRX BIOPHARMA DL cannot be verified against its exchange. It appears AZURRX BIOPHARMA is not available for investing at the moment. Please verify the symbol is currently traded on Frankfurt Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AZURRX BIOPHARMA stock to make a market-neutral strategy. Peer analysis of AZURRX BIOPHARMA could also be used in its relative valuation, which is a method of valuing AZURRX BIOPHARMA by comparing valuation metrics with similar companies.

AZURRX BIOPHARMA Corporate Directors

AZURRX BIOPHARMA corporate directors refer to members of an AZURRX BIOPHARMA board of directors. The board of directors generally takes responsibility for the AZURRX BIOPHARMA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AZURRX BIOPHARMA's board members must vote for the resolution. The AZURRX BIOPHARMA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Alastair Riddell - Independent DirectorProfile
Charles Casamento - Independent DirectorProfile
Maged Shenouda - CFO, DirectorProfile
Vern Schramm - Independent DirectorProfile
Check out Trending Equities. Note that the AZURRX BIOPHARMA information on this page should be used as a complementary analysis to other AZURRX BIOPHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Tools for AZURRX Stock

When running AZURRX BIOPHARMA price analysis, check to measure AZURRX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AZURRX BIOPHARMA is operating at the current time. Most of AZURRX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of AZURRX BIOPHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AZURRX BIOPHARMA's price. Additionally, you may evaluate how the addition of AZURRX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go